After the FDA delivered an approval to this low float biotech, its already mammoth potential grew even bigger. In line with the primed nano-cap market, see why this company is a potential goldmine.
Month:
Orphan Drug Designation and New Patent Means Immense Potential For This Micro-Float
This Orphan Drug Designated micro-float was just granted it’s 8th Patent after bouncing off it’s 52-week low, prompting a Wall St. Analyst to assign a +500% price target.
Senior Zack’s Analyst Provides 1,832 Percent Target On This Small Cap Tech Stock
After partnering with AT&T and Verizon and receiving a Zack’s Analyst Valuation target 1,832% above market price, this nano-cap tech stock could experience a huge growth period. Now is the time to watch it like a hawk!
Senior Life Sciences Analyst From Noble Financial Says This Gene Therapy Stock Could Climb Over 400%
Robert LeBoyer, a Senior Life Sciences Analyst at Noble Financial doubled down on his Outperform rating with a 400% upside after this company signed an exclusive University license agreement.
This Prime Opportunity to Hedge Against The Looming Recession Is On Your Screen Right Now
With a market recession looming overhead and an increasing surge of online commerce, this pawn service connection app is filling a huge technical gap for millions, and our portfolios
Insiders Are Buying This Medical Tech Goldmine And It’s Breaking Out
This recent medical device stock’s moderate float breakout presented mammoth potential and insiders are amassing shares. Get your eyes on this one early!
Breakthrough Fusion Gene Map Technology Announcement Takes Hold of $15 Billion Leukemia Treatment Market
This biotech company has been flying under the radar until now. With their recent FDA Approval announcement for Fusion Gene Map Technology and a patent approval, they are primed for an industry-shaking explosion.
Phase 1 Release for This Big Data Powerhouse Means Big Opportunity
With the release of Phase 1 of Singularity and the additions of more powerful technologies, this audience acquisition powerhouse is taking full advantage of machine-learning and sustained revenue growth.
